Pharmacia Upjohn Study Suggests
Selected Abstract
Pharmacia & Upjohn Study Suggests Investigational New Antibiotic ZYVOX(TM) (linezolid) May Result in Faster Hospital Discharge When Treating MRSS Infections.
ORLANDO, Fla., Dec. 6 /PRNewswire/ -- Results of an open-label Phase III clinical trial involving patients with methicillin-resistant Staphylococcus species (MRSS) infections suggest that individuals who received ZYVOX(TM) (linezolid), an investigational new antibiotic being developed by Pharmacia ... December 6, 1999; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Pharmacia & Upjohn Study Suggests Investigational New Antibiotic ZYVOX(TM) (linezolid) May Result in Faster Hospital Discharge When Treating MRSS Infections.
|
